Tandem Diabetes Care Inc. | Ownership
Companies that own Tandem Diabetes Care Inc.
BlackRock Fund Advisors
2,713,060
4.74%
2,671,340
0.01%
06/30/2018
Federated Global Investment Management Corp.
2,656,500
4.63%
406,500
0.87%
06/30/2018
Frontier Capital Management Co. LLC
2,633,456
4.59%
-87,481
0.79%
06/30/2018
Deerfield Management Company LP
2,573,305
4.5%
2,255,305
3.36%
06/30/2018
Fred Alger Management, Inc.
1,970,184
3.44%
1,950,184
0.34%
06/30/2018
First Light Asset Management LLC
1,904,260
3.33%
-2,829,978
11.56%
06/30/2018
The Vanguard Group, Inc.
1,820,792
3.18%
449,696
0%
06/30/2018
OrbiMed Advisors LLC
1,689,000
2.95%
1,689,000
0.8%
06/30/2018
Point72 Asset Management LP
1,239,600
2.17%
1,239,600
0.28%
06/30/2018
SSgA Funds Management, Inc.
1,213,913
2.12%
1,179,964
0%
06/30/2018
| Address |
11075 Roselle Street
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.tandemdiabetes.com |
| Updated |
07/08/2019 |
| Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. |
